As AI continues to advance and integrate into our daily lives, it's essential to consider the potential implications and consequences of this rapidly evolving technology on humanity and the world at large.

A recent discovery has revealed that private system prompts can be extracted with the right questions, compromising their security and confidentiality

Join Jason Koebler and Joseph Cox from 404 Media as they discuss the technology used by ICE, Flock, and the current state of surveillance in the US

In a significant reversal of policy, Nvidia announced it will resume sales of its H20 AI chips to China, after receiving new export licenses from the U.S. government. The decision is expected to unlock up to $10.5 billion in lost revenue for 2025, marking a critical turning point in the global AI chip race.

Google Fiber and Nokia have partnered to test network slicing for home broadband, an innovation that allows households to allocate separate high-priority bandwidth lanes for different use cases—like online gaming, video streaming, and secure banking. The move signals a significant leap toward customized, AI-optimized consumer internet.

In a landmark moment for autonomous vehicles, Tesla officially launched its robotaxi service in Austin, Texas today. The debut marks the company’s long-awaited entry into the self-driving ride-hailing market, with a limited fleet and a gradual rollout strategy focused on safety, performance, and public trust.

Jennifer Lopez is stepping into a new chapter of self-empowerment and reinvention following her reported divorce from Ben Affleck. The global superstar is focusing on her career, family, and personal growth, signaling a strong and stylish return to independence.

You’ve probably seen the terms React, React.js, and ReactJS used interchangeably—and that’s because in most casual contexts, they all refer to the same thing. But here's a clear breakdown so you understand the subtle differences and naming conventions

Indian pharmaceutical stocks saw a significant dip on May 12, 2025, following the announcement by U.S. President Donald Trump regarding plans to reduce prescription drug prices by up to 80%. The executive order, which introduces a “most favored nation” approach, aims to ensure the U.S. will not pay more for drugs than the lowest price paid by other countries. This move has led to concerns within the global pharma market, particularly affecting Indian companies with large stakes in the U.S. pharmaceutical market.